Comparative analysis of xanafide cytotoxicity in breast cancer cell lines

Xanafide, a DNA-intercalating agent and topoisomerase II inhibitor, has previously demonstrated comparable cytotoxicity to the parent drug amonafide (NSC 308847). The current study was conducted to investigate further the anti-proliferative effects of xanafide in human breast cancer cell lines, in v...

Descripción completa

Detalles Bibliográficos
Autores principales: Alami, N, Paterson, J, Belanger, S, Juste, S, Grieshaber, C K, Leyland-Jones, B
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2007
Materias:
Translational Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2359668/
https://www.ncbi.nlm.nih.gov/pubmed/17551498
http://dx.doi.org/10.1038/sj.bjc.6603829

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2359668/
https://www.ncbi.nlm.nih.gov/pubmed/17551498
http://dx.doi.org/10.1038/sj.bjc.6603829

Ejemplares similares